Apolipoprotein C-III's role in cardiovascular diseases, a short review.

Author:

Emilian OlteanuORCID,Gheorghe-Emilian OlteanuORCID

Abstract

In this short review we show the important role played by apoC-III in the lipid dysregulation present in the majority of cardiovascular diseases. With emphasis on the mutations present in a minority of individuals that confer protection. With this in mind we state that apoC-III should be considered a valid target for pharmaceutical intervention and cardiovascular disease control and progression.

Publisher

ScienceOpen

Reference16 articles.

1. Transcriptional suppression of human apolipoproteina4 and apolipoproteinc3 genes by phorbol myristate acetate in hepatic and intestinal cells;Li G, Yang H, Li W, Qu S, Wang X, Li Y, Li R, Wang Z;Bio-Med Mat Eng,2014

2. Regulation of hepatic apoc3 expression by pgc-1ß mediates hypolipidemic effect of nicotinic acid;Hernandez C, Molusky M, Li Y, Li S, Lin J;Cell Metab,2010

3. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice;Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow J;Science,1990

4. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia;Maeda N, Li H, Lee D, Oliver P, Quarfordt S, Osada J;J Biol Chem,1994

5. The role and mode of action of apolipoproteins ciii and av: synergistic actors in triglyceride metabolism?;van Dijk K, Rensen P, Voshol P, Havekes L;Curr Opin Lipidol,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3